Itracoe Gel contains Itraconazole 1% w/w, a broad-spectrum antifungal agent belonging to the triazole class. It is indicated for the topical treatment of various superficial fungal infections, including dermatophytosis, candidiasis, and pityriasis versicolor. Itraconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The gel formulation allows for targeted application to affected areas, promoting rapid absorption and localized action with minimal systemic exposure. Itracoe Gel is suitable for use on skin lesions presenting with erythema, scaling, and pruritus associated with fungal infections. It should be applied once or twice daily to the affected area after cleansing and drying the skin, with the duration of therapy typically ranging from 2 to 4 weeks depending on the severity and type of infection. Caution is advised in patients with known hypersensitivity to itraconazole or other azole antifungals. Adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the application site. Itracoe Gel is contraindicated in cases of open wounds or mucosal infections. Proper adherence to prescribed treatment ensures optimal therapeutic outcomes and reduces the risk of recurrence.